Swipe om te navigeren naar een ander artikel
Genetic research in autism depends on the willingness of individuals with autism to participate; thus, there is a duty to assess participants’ needs in the research process. We report on families’ motives and expectations related to their participation in autism genetic research. Respondents valued having a genetic result, as it alleviates guilt, promotes awareness, and may be used to tailor interventions and for family planning. The act of participating was distinctly significant, as it provided personal control, a connection to autism experts, networking with families, and hope for the future. The results of this study highlight complex factors involved in families’ decisions to participate in autism genetic research and provide points to consider for this population of research participants.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Abelson, J., Miller, F. A., & Giacomini, M. (2009). What does it mean to trust a health care system? A qualitative study of Canadian health care values. Health Policy, 91(1), 60–63. CrossRef
Canvin, K., & Jacoby, A. (2006). Duty, desire or indifference? A qualitative study of patient decisions about recruitment to an epilepsy treatment trial. Trials, 12(7), 19–32.
Charmaz, K. (2000). Grounded theory objectives and constructive methods (2nd ed., pp. 509–535). Thousand Oaks, CA: Sage.
Croyle, R. T., Dutson, D. S., Tran, V. T., & Sun, Y. C. (1995). Need for certainty and interest in genetic testing. Women’s Health, 1(4), 329–339. PubMed
Fombonne, E. (2005). Epidemiological studies of autism and pervasive developmental disorders. In F. Volkmar (Ed.), Handbook of autism and pervasive developmental disorders (3rd ed., pp. 42–69). New York: Wiley.
Guest, G., Bunce, A., & Johnson, L. (2006). How many interviews are enough? An experiment with data saturation and variability. Field Methods, 18(1), 59–82. CrossRef
Hayeems, R. Z., Miller, F. A., Li, L., & Bytautas, J. P. (2011). Not so simple: A quasi-experimental study of how researchers adjudicate genetic research results. European Journal of Human Genetics, 19(7), 1–8. CrossRef
MacLeod, R., Craufurd, D., & Booth, K. (2003). Patients’ perceptions of what makes genetic counseling effective: An interpretative phenomenological analysis. Journal of Health Psychology, 7(2), 145–156. CrossRef
McAllister, M., Wood, A. M., Dunn, G., Shiloh, S., & Todd, C. (2011). The perceived personal control (PPC) questionnaire: Reliability and validity in a sample from the United Kingdom. American Journal of Medical Genetics, 158A(2), 367–372. PubMed
Miller, F. A., Giacomini, M., Ahern, C., Roberts, J. S., & de Laat, S. (2008). When research seems like clinical care: A qualitative study of the communication of individual cancer genetic research results. BMC Medical Ethics, 9(4), 1–12.
Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., et al. (2010a). Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Medical Genetics, 86(5), 749–764.
Miller, F. A., Hayeems, R. Z., Li, L., & Bytautas, J. P. (2012b). One thing leads to another: The cascade of obligations when researchers report genetic research results to study participants. European Journal of Human Genetics, 18(8), 867–871. CrossRef
Ozonoff, S., Young, G. S., Carter, A., Messinger, D., Yirmiya, N., Zwaigenbaum, L., et al. (2011). Recurrence risk for autism spectrum disorders: A baby sibling’s research consortium study. Pediatrics, 128(3), e488–e495. PubMed
Patton, M. Q. (2002). Qualitative research and evaluation methods (3rd ed.). Thousand Oaks/London/Delhi: Sage.
Ritvo, E. R., Jorde, L. B., Mason-Brothers, A., Freeman, B. J., Pingree, C., Jones, M. B., et al. (1989). The UCLA-University of Utah epidemiologic survey of autism: Recurrence risk estimates and genetic counseling. American Journal of Psychiatry, 146(8), 1032–1036. PubMed
Sanders, J., & Morgan, S. (1997). Family stress and adjustment as perceived by parents of children with autism or Down syndrome: Implications for interventions. Child & Family Behavior Therapy, 19(4), 15–32. CrossRef
Shen, Y., Dies, K. A., Holm, I. A., Bridgemohan, C., Sobeih, M. M., Caronna, E. B., et al. (2010). Clinical genetic testing for patients with autism spectrum disorders. Pediatrics, 125(4), 727–735. CrossRef
Simons Foundation. (2010). Simons VIP connect: Simons variation in individuals project (VIP). Copyright, Simons Foundation, 2010. http://www.simonsvipconnect.org/. Accessed March 16, 2012.
Tambor, E. S., Bernhardt, B. A., Chase, G. A., Faden, R. R., Geller, G., Hofman, K. J., et al. (1994). Offering cystic fibrosis carrier screening to an HMP population: Factors associated with utilization. American Journal of Human Genetics, 55(4), 626–637. PubMed
Treloar, S. A., Morley, K. I., Taylor, S. D., & Hall, W. D. (2007). Why do they do it? A pilot study towards understanding participant motivation and experience in a large genetic epidemiological study of endometriosis. Community Genetics, 10(2), 60–71. CrossRef
- Parents’ Perspectives on Participating in Genetic Research in Autism
Stephen W. Scherer
Fiona A. Miller
- Springer US